Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Dodge & Cox Stock I

Vanguard PRIMECAP Inv

T. Rowe Price US Small-Cap Core Equity

Dodge & Cox Balanced I

Dodge & Cox Balanced Composite

CREF Stock R1

DFA US Small Cap Value I

Dodge & Cox Global Stock I

PRIMECAP Odyssey Growth

T. Rowe Price US Smlr Cm Eq A USD

PRIMECAP Odyssey Stock

T. Rowe Price Instl Small-Cap Stock

Vanguard Total Stock Mkt Idx Inv

Vanguard Small Cap Index

CI Global Leaders Fund D

Vanguard Capital Opportunity Inv

Vanguard Small Cap Value Index Inv

Vanguard PRIMECAP Core Inv

Vanguard Institutional Extnd Mkt Idx Tr

T. Rowe Price Small-Cap Stock

Dodge & Cox

PRIMECAP Management Company

JPMorgan Chase & Co

State Street Corp

Millennium Management LLC

Geode Capital Management, LLC

Citadel Advisors Llc

Manufacturers Life Insurance Co

Balyasny Asset Management LLC

Charles Schwab Investment Management Inc

Morgan Stanley - Brokerage Accounts

Iron Triangle Partners LP

Vanguard Group Inc

BlackRock Inc

Black Creek Investment Management Inc

T. Rowe Price Investment Management,Inc.

Dimensional Fund Advisors, Inc.

Nuveen Asset Management, LLC

Shapiro Capital Management Co Inc

Magnetar Financial LLC

Elanco Animal Health

Mr. Jeffrey N. Simmons

President, CEO & Director

Mr. Todd S. Young J.D.

Executive VP & CFO

Dr. Ramiro Martin Cabral

Executive Vice President of Elanco International

Dr. Ellen  de Brabander Ph.D.

Executive Vice President of Research, Development & Regulatory Affairs

Mr. Timothy J. Bettington

Executive Vice President of Corporate Strategy & Market Development

Mr. James M. Meer

Senior VP & Chief Accounting Officer

Mr. Chris  Keeley

Senior VP & Chief Information Officer

Mr. David S. Kinard

Executive Vice President of Human Resources, Corporate Communications & Administration

Ms. Katy  Grissom

Head of Investor Relations

Ms. Shiv  O'Neill

Executive Vice President, General Counsel & Corporate Secretary

Elanco Animal Health (ELAN) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Elanco Animal Health (ELAN) Earnings Report Date and History | NYSE

ELAN's next earnings is on February 24, 2025 (Before Market Open)

When is the earnings report for ELAN?

ELAN Earnings History

ELAN Stock Discussion Forum and Message Board

News for NYSE: ELAN